Laguna Clinical Research Associates | Laredo Laguna

Research site

Location

2344 Laguna Del Mar Court, Laredo, Texas, United States of America

Site insights

Top conditions

Top treatments

Pembrolizumab

Tonlamarsen

Molnupiravir

TCMCB07

Remdesivir

Sacituzumab

DFMO

PF-07817883

IONIS-AGT-LRx

AMXT 1501

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Laguna Enrollment

Verified by this site

Active trials

6 of 11 total trials

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) (MOVe-NOW)

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symp...

Enrolling

Coronavirus Disease (COVID-19)

Drug: Placebo

Drug: Molnupiravir

A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza (ANCHOR)

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to pla...

Active, not recruiting

Influenza

Combination Product: CD388 Injection

Combination Product: Placebo

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizu...

Enrolling

Triple-Negative Breast Cancer

Biological: Pembrolizumab

Biological: Sacituzumab tirumotecan

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

This is a randomized, double-blind, placebo-controlled basket trial evaluating mifomelatide (TCMCB07) administered daily by subcutaneous (SC) injecti...

Enrolling

Cancer Weight Loss

Drug: TCMCB07

Drug: Placebo

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

This study will evaluate the safety, tolerability, and preliminary effectiveness of AMXT 1501 and DFMO when combined with standard treatments for adv...

Enrolling

HER2-low Hormone Receptor Positive Breast Cancer

Melanoma (Skin Cancer)

Drug: Pembrolizumab

Drug: DFMO

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension (KARDINAL-ASH)

The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and c...

Enrolling

Hypertension

Hypertensive Emergency

Drug: Placebo

Drug: Tonlamarsen